Kezar Life Sciences Stock Probability Of Bankruptcy

KZR Stock  USD 6.75  0.03  0.44%   
Kezar Life's chance of distress is over 50% at this time. It has a moderate odds of going through some financial crunch in the next 2 years. Kezar Life's Probability of distress is determined by interpolating and adjusting Kezar Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Kezar balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Kezar Life Piotroski F Score and Kezar Life Altman Z Score analysis.
  
As of 12/15/2024, Market Cap is likely to drop to about 750.6 M. In addition to that, Enterprise Value is likely to drop to about 732.5 M

Kezar Life Sciences Company probability of distress Analysis

Kezar Life's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

 = 

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Kezar Life Probability Of Bankruptcy

    
  Over 51%  
Most of Kezar Life's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kezar Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of Kezar Life probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Kezar Life odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Kezar Life Sciences financial health.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kezar Life. If investors know Kezar will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kezar Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(13.12)
Revenue Per Share
0.962
Return On Assets
(0.28)
Return On Equity
(0.51)
The market value of Kezar Life Sciences is measured differently than its book value, which is the value of Kezar that is recorded on the company's balance sheet. Investors also form their own opinion of Kezar Life's value that differs from its market value or its book value, called intrinsic value, which is Kezar Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kezar Life's market value can be influenced by many factors that don't directly affect Kezar Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kezar Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kezar Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kezar Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Kezar Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Kezar Life is extremely important. It helps to project a fair market value of Kezar Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Kezar Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kezar Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kezar Life's interrelated accounts and indicators.
0.990.91-0.39-0.850.60.650.91-0.181.00.970.570.990.980.9-0.350.92-0.890.850.420.49
0.990.91-0.3-0.830.580.610.89-0.340.990.970.621.00.970.86-0.320.9-0.860.820.390.46
0.910.91-0.22-0.970.850.821.0-0.270.910.930.590.930.910.83-0.680.92-0.930.890.720.74
-0.39-0.3-0.220.18-0.050.08-0.22-0.47-0.4-0.29-0.11-0.31-0.33-0.23-0.02-0.270.34-0.120.020.03
-0.85-0.83-0.970.18-0.93-0.89-0.990.13-0.85-0.89-0.49-0.85-0.85-0.820.76-0.930.94-0.93-0.77-0.84
0.60.580.85-0.05-0.930.890.87-0.050.60.690.350.610.60.61-0.920.77-0.80.820.890.94
0.650.610.820.08-0.890.890.850.040.640.690.330.630.670.76-0.790.77-0.760.890.830.85
0.910.891.0-0.22-0.990.870.85-0.220.90.920.560.920.90.84-0.70.93-0.940.910.740.76
-0.18-0.34-0.27-0.470.13-0.050.04-0.22-0.18-0.23-0.45-0.32-0.21-0.030.04-0.10.09-0.02-0.050.04
1.00.990.91-0.4-0.850.60.640.9-0.180.970.560.990.980.9-0.340.92-0.890.850.410.48
0.970.970.93-0.29-0.890.690.690.92-0.230.970.540.970.950.87-0.40.97-0.910.90.430.61
0.570.620.59-0.11-0.490.350.330.56-0.450.560.540.620.460.22-0.260.36-0.350.330.260.28
0.991.00.93-0.31-0.850.610.630.92-0.320.990.970.620.980.86-0.370.91-0.880.830.440.49
0.980.970.91-0.33-0.850.60.670.9-0.210.980.950.460.980.95-0.360.94-0.920.870.440.48
0.90.860.83-0.23-0.820.610.760.84-0.030.90.870.220.860.95-0.380.92-0.90.910.480.52
-0.35-0.32-0.68-0.020.76-0.92-0.79-0.70.04-0.34-0.4-0.26-0.37-0.36-0.38-0.490.6-0.57-0.98-0.83
0.920.90.92-0.27-0.930.770.770.93-0.10.920.970.360.910.940.92-0.49-0.960.950.530.68
-0.89-0.86-0.930.340.94-0.8-0.76-0.940.09-0.89-0.91-0.35-0.88-0.92-0.90.6-0.96-0.9-0.65-0.68
0.850.820.89-0.12-0.930.820.890.91-0.020.850.90.330.830.870.91-0.570.95-0.90.60.8
0.420.390.720.02-0.770.890.830.74-0.050.410.430.260.440.440.48-0.980.53-0.650.60.77
0.490.460.740.03-0.840.940.850.760.040.480.610.280.490.480.52-0.830.68-0.680.80.77
Click cells to compare fundamentals
The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
Competition

Based on the latest financial disclosure, Kezar Life Sciences has a Probability Of Bankruptcy of 51%. This is 17.81% higher than that of the Biotechnology sector and 7.0% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 28.04% lower than that of the firm.

Kezar Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kezar Life's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kezar Life could also be used in its relative valuation, which is a method of valuing Kezar Life by comparing valuation metrics of similar companies.
Kezar Life is currently under evaluation in probability of bankruptcy category among its peers.

Kezar Life Main Bankruptcy Drivers

201920202021202220232024 (projected)
Return On Assets(0.35)(0.26)(0.24)(0.22)(0.46)(0.48)
Net Debt(8.6M)(15.8M)(48.8M)(19.2M)(16.6M)(17.4M)
Total Current Liabilities6.0M6.4M8.2M11.0M17.7M18.6M
Non Current Liabilities Total5.5M4.4M12.8M18.7M15.9M16.7M
Total Assets89.5M151.8M217.9M299.6M221.2M159.6M
Total Current Assets81.1M144.8M211.7M285.7M207.0M151.6M
Total Cash From Operating Activities(29.9M)(36.9M)(42.4M)(58.8M)(81.6M)(77.6M)

Kezar Life ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Kezar Life's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Kezar Life's managers, analysts, and investors.
Environmental
Governance
Social

Kezar Fundamentals

About Kezar Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Kezar Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kezar Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kezar Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with Kezar Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kezar Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kezar Life will appreciate offsetting losses from the drop in the long position's value.

Moving against Kezar Stock

  0.44PTN Palatin TechnologiesPairCorr
  0.37MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
The ability to find closely correlated positions to Kezar Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kezar Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kezar Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kezar Life Sciences to buy it.
The correlation of Kezar Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kezar Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kezar Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kezar Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Kezar Stock Analysis

When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.